Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
8.04
+0.18 (2.29%)
Nov 21, 2024, 1:08 PM EST - Market open
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for FHTX stock have an average target of 16, with a low estimate of 9.00 and a high estimate of 20. The average target predicts an increase of 99.00% from the current stock price of 8.04.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 24, 2024.
Analyst Ratings
The average analyst rating for FHTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $6 → $9 | Hold | Maintains | $6 → $9 | +11.94% | Sep 24, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +123.88% | Sep 3, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $20 | Buy | Initiates | $20 | +148.76% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +148.76% | Aug 12, 2024 |
| Wedbush | Wedbush | Buy Reiterates $13 | Buy | Reiterates | $13 | +61.69% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
31.19M
from 34.16M
Decreased by -8.69%
Revenue Next Year
33.92M
from 31.19M
Increased by 8.77%
EPS This Year
-1.83
from -2.34
EPS Next Year
-1.59
from -1.83
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 47.3M | 52.5M | 63.0M | ||
| Avg | 31.2M | 33.9M | 42.1M | ||
| Low | 25.4M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 38.3% | 68.3% | 85.7% | ||
| Avg | -8.7% | 8.8% | 24.2% | ||
| Low | -25.7% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.64 | -1.06 | -1.08 | ||
| Avg | -1.83 | -1.59 | -1.62 | ||
| Low | -2.09 | -2.26 | -2.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.